Literature DB >> 24714790

Sildenafil for noncompaction cardiomyopathy treatment in a child: case report.

Ana Carolina Costa Redondo1, Gabriela Fuenmayor1, Karen Saori Shiraishi1, Simone Rolim F Fontes1, Patrícia Figueiredo Elias1, Rogerio Souza1, Ieda Biscegli Jatene1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24714790      PMCID： PMC3987316          DOI： 10.5935/abc.20140024

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  10 in total

1.  Isolated noncompaction of the ventricular myocardium: clinical and molecular aspects of a rare cardiomyopathy.

Authors:  Eduardo Zambrano; Stephen J Marshalko; C Carl Jaffe; Pei Hui
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

2.  Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis.

Authors:  E N Oechslin; C H Attenhofer Jost; J R Rojas; P A Kaufmann; R Jenni
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

3.  Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.

Authors:  Rakesh C Kukreja; Fadi N Salloum; Anindita Das; Saisudha Koka; Ramzi A Ockaili; Lei Xi
Journal:  Exp Clin Cardiol       Date:  2011

Review 4.  Cardiac uses of phosphodiesterase-5 inhibitors.

Authors:  Bryan G Schwartz; Laurence A Levine; Gary Comstock; Vera J Stecher; Robert A Kloner
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

5.  Sildenafil vs. sodium before nitroprusside for the pulmonary hypertension reversibility test before cardiac transplantation.

Authors:  Aguinaldo Figueiredo Freitas; Fernando Bacal; José de Lima Oliveira Júnior; Alfredo Inácio Fiorelli; Ronaldo Honorato Santos; Luiz Felipe Pinho Moreira; Christiano Pereira Silva; Sandrigo Mangini; Jeane Mike Tsutsui; Edimar Alcides Bocchi
Journal:  Arq Bras Cardiol       Date:  2012-08-16       Impact factor: 2.000

6.  Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background.

Authors:  F Ichida; Y Hamamichi; T Miyawaki; Y Ono; T Kamiya; T Akagi; H Hamada; O Hirose; T Isobe; K Yamada; S Kurotobi; H Mito; T Miyake; Y Murakami; T Nishi; M Shinohara; M Seguchi; S Tashiro; H Tomimatsu
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

Review 7.  Noncompaction cardiomyopathy: a current view.

Authors:  Leonardo Vieira da Rosa; Vera Maria Cury Salemi; Leonardo Machado Alexandre; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2011-07       Impact factor: 2.000

8.  Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantation.

Authors:  Miguel Angel Gómez-Sánchez; Carlos Saenz De La Calzada; Pilar Escribano Subías; Juan Francisco Delgado Jiménez; María Lázaro Salvador; Agustín Albarrán González; Luis Cea Calvo
Journal:  Eur J Heart Fail       Date:  2004-08       Impact factor: 15.534

Review 9.  Heart failure in infants and children.

Authors:  Erin Madriago; Michael Silberbach
Journal:  Pediatr Rev       Date:  2010-01

10.  Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction.

Authors:  Edimar Alcides Bocchi; Guilherme Guimarães; Amilcar Mocelin; Fernando Bacal; Giovanni Bellotti; José Franchini Ramires
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690
  10 in total
  1 in total

1.  Is sildenafil a therapeutic option for noncompaction?

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Arq Bras Cardiol       Date:  2014-09       Impact factor: 2.000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.